What kind of drugs does estramustine (Adelox) belong to and its mechanism of action?

Estramustine (Estramustine) is an anti-tumor drug that is a chemical drug that combines antimetabolites and anti-androgens. Its unique feature is that it has both an estrogen structure and a nitrogen mustard derivative structure, so it has a dual mechanism of action in anti-cancer treatment. It is mainly used clinically to treat prostate cancer, especially patients with advanced or hormone-refractory prostate cancer. It provides patients with a treatment plan that targets cell proliferation and hormone-dependent tumors.

In terms of its mechanism of action, estramustine inhibits the polymerization of tubulin through its nitrogen mustard derivative structure, thereby interfering with the formation of the cytoskeleton and the mitosis process, leading to blocked division and apoptosis of cancer cells. Microtubules are indispensable structures in cell division. Interfering with the function of microtubules can effectively inhibit the proliferation rate of tumor cells and slow down tumor growth. In addition, the drug's anti-androgenic effects inhibit prostate cancer cells' dependence on androgens, further reducing the risk of tumor progression.

The antiandrogenic effects of estramustine are primarily exerted through its estrogenic structure. The estrogen moiety can bind to estrogen receptors in the body, interfere with the androgen signaling pathway, and inhibit hormone-driven proliferation of prostate cancer cells. This dual mechanism makes estramustine more effective in the treatment of hormone-dependent tumors, especially for patients who do not respond well to simple androgen deprivation therapy. At the same time, it can also improve symptoms related to bone metastasis and improve patients' quality of life.

It should be noted that although estramustine has outstanding anti-cancer effects, its estrogenic effect may cause side effects such as blood clots, breast hyperplasia, or cardiovascular risks. Therefore, doctors' instructions should be strictly followed during use, and blood indicators and cardiovascular health status should be monitored to ensure the efficacy of the drug while minimizing safety risks. Reasonable dosage and individualized treatment are the keys to optimal efficacy of estramustine.

Reference materials:https://www.drugs.com/